Get started
Author

Michelle Iocolano

The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
2023 · Cole Friedes, Michelle Iocolano, et al. · Radiotherapy and Oncology · 43
The QuitIT Coping Skills Game for Promoting Tobacco Cessation Among Smokers Diagnosed With Cancer: Pilot Randomized Controlled Trial
2018 · Paul Krebs, Jack Burkhalter, et al. · JMIR mhealth and uhealth · 40
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation
2023 · Nikhil Yegya-Raman, Sang Ho Lee, et al. · Radiotherapy and Oncology · 25
PDF
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
2023 · Cole Friedes, Michelle Iocolano, et al. · International Journal of Radiation Oncology*Biology*Physics · 24
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy
2020 · Annemarie F. Shepherd, Michelle Iocolano, et al. · Practical Radiation Oncology · 24
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
2023 · Nikhil Yegya-Raman, Cole Friedes, et al. · International Journal of Radiation Oncology*Biology*Physics · 22
An eHealth Intervention to Increase Physical Activity and Healthy Eating in Older Adult Cancer Survivors: Summative Evaluation Results
2017 · Paul Krebs, Jonathan Shtaynberger, et al. · JMIR Cancer · 21
PDF
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC
2021 · Annemarie F. Shepherd, Anthony F. Yu, et al. · JTO Clinical and Research Reports · 20
Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy
2019 · Michelle Iocolano, Aaron T. Wild, et al. · Acta Oncologica · 20
PDF
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
2023 · Cole Friedes, Nikhil Yegya-Raman, et al. · Clinical Lung Cancer · 16
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
2023 · Nikhil Yegya-Raman, Nikhil Yegya-Raman, et al. · International Journal of Radiation Oncology*Biology*Physics · 14
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era
2024 · Michelle Iocolano, Nikhil Yegya‐Raman, et al. · Cancer · 10
PDF
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
2023 · Nikhil Yegya-Raman, Cole Friedes, et al. · Clinical Lung Cancer · 8
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
2023 · Adam Barsouk, Cole Friedes, et al. · Clinical Lung Cancer · 7
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer
2023 · Justin M. Haseltine, Aditya Apte, et al. · Physics and Imaging in Radiation Oncology · 7
Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
2020 · Michelle Iocolano, Seth Blacksburg, et al. · Frontiers in Oncology · 7
PDF
Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy
2025 · Jenna Rocchetti, Nikhil Yegya-Raman, et al. · Radiotherapy and Oncology · 5
PDF
Primary Tumor Failure After Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Brief Report on the Implications for NRG LU-008
2025 · Cole Friedes, Nikhil Yegya-Raman, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy
2025 · Cole Friedes, Michelle Iocolano, et al. · American Journal of Clinical Oncology · 2
Statin therapy, cardiac events, and survival in patients with non-small cell lung cancer receiving definitive radiotherapy
2023 · Nikhil Yegya-Raman, Cole Friedes, et al. · Radiotherapy and Oncology · 2
Palliative Care Delivery Systems and Integration With Palliative Care Teams
2023 · Michelle Iocolano, Alyssa Langi, et al. · Seminars in Radiation Oncology · 2
PDF
Salvage Thoracic Reirradiation for Recurrent Non-Small Cell Lung Cancer: Clinical Efficacy and the Impact of Consolidative Immunotherapy
2025 · Jenna Rocchetti, Nikhil Yegya-Raman, et al. · SSRN Electronic Journal · 1
Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation
2023 · N. Yegya-Raman, S.H. Lee, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiotherapy (IMRT) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation: A Retrospective Cohort Study
2023 · M. Iocolano, N. Yegya-Raman, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Patterns of Failure, Volume of Disease Progression, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors (ICI)
2023 · C. Friedes, N. Yegya-Raman, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Works count: 61
Citation count: 330
H-index: 11
I10-index: 11
Year
Topic
Type